Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 389 publications
Clinical characteristics and risk factors associated with severe community-acquired pneumonia infected by Chlamydia psittaci.
Journal: Microbiology spectrum
Published: September 24, 2025
Sulbactam-Durlobactam Plus Ceftriaxone Dosing and Novel Treatment Regimens for Mycobacterium abscessus Lung Disease.
Journal: bioRxiv : the preprint server for biology
Published: August 13, 2025
Omadacycline exhibits anti-inflammatory properties and improves survival in a murine model of post-influenza MRSA pneumonia.
Journal: Antimicrobial agents and chemotherapy
Published: August 04, 2025
Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019-2021).
Journal: Journal of clinical microbiology
Published: June 24, 2025
In Vitro Activity of Novel Antibiotics Against Corynebacterium spp. Clinical Isolates Responsible for Difficult-to-Treat Infections.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: June 23, 2025
LC-MS/MS quantification of omadacycline in human plasma for therapeutic drug monitoring: method development and clinical application.
Journal: Scientific reports
Published: June 13, 2025
In Vitro Susceptibility to Imipenem/Relebactam and Comparators in a Multicentre Collection of Mycobacterium abscessus Complex Isolates.
Journal: Antibiotics (Basel, Switzerland)
Published: June 04, 2025
The Evolution of Virulence of Carbapenem-Resistant Klebsiella pneumoniae from the Same Source Under the Pressure of Omadacycline Treatment.
Journal: Infection and drug resistance
Published: May 26, 2025
In vitro Activity of the Novel Tetracyclines Derivative, Zifanocycline Against Mycobacterium abscessus.
Journal: Infection and drug resistance
Published: May 21, 2025
Clinical Efficacy and Safety of Omadacycline Versus Tigecycline in Treating Severe Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacilli: A Retrospective Cohort Study.
Journal: Infection and drug resistance
Published: May 18, 2025
Omadacycline in the treatment of severe Q fever pneumonia during an influenza epidemic: a case report with literature review.
Journal: Frontiers in medicine
Published: May 10, 2025
Last Updated: 10/31/2025